Advertisement
Screener

DERMATA THERAPEUTICS, INC. (DRMA) Stock Issued During Period, Value, Other

2.8 / 5 stars · 68/120 Roast Me

DERMATA THERAPEUTICS, INC. Stock Issued During Period, Value, Other

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • DERMATA THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2026-03-31 was $1.99M, a 65.33% decline year-over-year.
  • DERMATA THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2025-03-31 was $5.75M.
  • DERMATA THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2024-09-30 was $1.48M.
  • DERMATA THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2025 was $356.38K, a 75.30% decline from fiscal 2024.
  • DERMATA THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2024 was $1.44M.
Period endStock Issued During Period, Value, Other 3 monthStock Issued During Period, Value, Other 12 month
2026-03-31$1.99M
10-Q · filed 2026-08-11
2025-12-31$356.38K
10-K · filed 2026-03-26
2025-03-31$5.75M
10-Q · filed 2025-11-14
2024-12-31$1.44M
10-K · filed 2026-03-26
2024-09-30$1.48M
10-Q · filed 2025-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
HCW Biologics Inc. (HCWB)United States$0.004B-6.15